Why the study?
Excess lipid droplets are frequently observed in arterial endothelial cells at sites of advanced atherosclerotic plaques, but the mechanism and implication are unknown.
TNFɑ promotes LDLR functions through combined increase at the cell surface and SR-B1 downregulation, which may have important implications on the progression of atherosclerosis.
Answers are grounded in this paper and cite their sources.
TNFα drives ACAT-resistant cholesterol accumulation in aortic endothelial cells; leaves open its role in plaque lipid dynamics.
Background Excess lipid droplets are frequently observed in arterial endothelial cells at sites of advanced atherosclerotic plaques. The mechanism or implication of this observation is unknown. Methods The role of tumor necrosis factor alpha (TNFɑ) in modulating low density lipoprotein (LDL) content in confluent primary human aortic endothelial cells (pHAECs) was investigated. Results TNFɑ promoted up to 2 folds increase in cellular cholesterol, which was resistant to ACAT inhibition. The cholesterol increase was associated with increased 125 I-LDL surface binding. Using the non-hydrolysable label, Dil, TNFɑ could induce a massive increase in Dil-LDL by over 200 folds. The elevated intracellular Dil-LDL was blocked with excess unlabeled LDL and PCSK9, but not oxidized LDL (oxLDL), RAP, or apoE depletion. Moreover, TNFɑ-induced increase of LDL-derived lipids was elevated through lysosome inhibition. Using specific LDLR antibody, the Dil-LDL accumulation was reduced by over 99%. Effects of TNFɑ included LDLR cell surface increase by 138%, and very large increases in ICAM-1 total and surface proteins, respectively. In contrast, that of scavenger receptor B1 (SR-B1) was reduced. Additionally, LDLR antibody bound rapidly in TNFɑ-treated cells by about 30 folds, inducing a migrating shift in the LDLR protein. The effect of TNFɑ on Dil-LDL accumulation was inhibited by the antioxidant tetramethythiourea (TMTU) dose-dependently, but not by downstream cascade inhibitors against NF-κB, stress kinases, ASK1, JNK, p38, or apoptosis caspases. Grown on transwell inserts, TNFɑ did not enhance apical (AP) to basolateral (BL) LDL cholesterol or Dil release. Conclusions It is concluded that TNFɑ promotes LDLR functions through combined increase at the cell surface and SR-B1 downregulation. This may have important implications on progression of atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Emmanuel U. Okoro (2021) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: